Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02768844 · ClinicalTrials.gov registry record · NA
Physiology and Therapeutic Management of Neonatal Abstinence Syndrome
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02768844: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT02768844 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02768844, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The overall purpose of this project is to to quantify the physiology of neonatal drug withdrawal and develop non-pharmacological techniques to help improve the therapeutic management of Neonatal Abstinence Syndrome (NAS).
Primary Outcome
Measure mean change in infant movement activity via limb sensors
Interventions
- OTHER Control
- DEVICE Stochastic Vibrotactile Stimulation (SVS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2011-04 |
| Est. Completion | 2019-12-15 |
| Phase | NA |
What the finished NCT02768844 record still lists
NCT02768844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02768844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02768844 about?
NCT02768844 is a clinical study titled "Physiology and Therapeutic Management of Neonatal Abstinence Syndrome". The overall purpose of this project is to to quantify the physiology of neonatal drug withdrawal and develop non-pharmacological techniques to help improve the therapeutic management of Neonatal Abstinence Syndrome (NAS).
What is the current status of trial NCT02768844?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2011-04. Estimated completion is 2019-12-15.
What interventions are being tested in trial NCT02768844?
The interventions under investigation include: Control (OTHER), Stochastic Vibrotactile Stimulation (SVS) (DEVICE).
Who is sponsoring clinical trial NCT02768844?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02768844's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia